Evidence map›Paper›PMID 21957309›Full record

ArticleJournal of virology2011

CD8+ T cell escape mutations in simian immunodeficiency virus SIVmac239 cause fitness defects in vivo, and many revert after transmission.

Philip A Mudd, Adam J Ericsen, Andrew D Walsh, Enrique J León, Nancy A Wilson, Nicholas J Maness, Thomas C Friedrich, David I Watkins

Abstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Philip A MuddDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, 555 Science Dr., Madison, WI 53711, USA.
Adam J Ericsen
Andrew D Walsh
Enrique J León
Nancy A Wilson
Nicholas J Maness
Thomas C Friedrich
David I Watkins
University of Wisconsin–Madison · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
ZOLEDRONATE PREVENTS BONE LOSS IN OVARIECTOMIZED RHESUS MONKEYSP51RR000167 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 1985 to 2011
$106.7M
MHC-bound, SIV-derived, CTL &HTL EpitopesR24RR015371 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2000 to 2011
$8.1M
A NOVEL, LOGICAL APPROACH TO HIV VACCINE DEVELOPMENTR01AI049120 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2001 to 2009
$7.6M
The Functional Significance of CTL EscapeR37AI052056 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2008 to 2017
$7.1M
MHC TYPING OF MACAQUES USED IN AIDS RESEARCHR24RR016038 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2001 to 2011
$6.3M
Minigene Vaccination with Early Presented Viral ProteinsR01AI076114 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI RAKASZ, EVA GIZELLA · 2007 to 2011
$3.3M
Virology Training ProgramT32AI078985 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI LAMBERT, PAUL F. · 2009 to 2018
$3.3M
Cryptic ORFs as a vaccine for HIVR21AI081590 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2009 to 2010
$386k
NCRR NIH HHS P51 RR000167NCRR NIH HHS R24 RR015371NCRR NIH HHS R24 RR016038NIAID NIH HHS R01 AI049120NIAID NIH HHS R01 AI076114NIAID NIH HHS R21 AI081590NIAID NIH HHS R37 AI052056NIAID NIH HHS T32 AI078985NIH HHS P51 OD011104
6 · The paper itself

Abstract

Virus-specific CD8(+) T lymphocytes select for escape mutations in human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV). To assess the effects of these mutations on viral fitness, we introduced escape mutations into 30 epitopes (bound by five major histocompatibility complex class I [MHC-I] molecules) in three different viruses. Two of these MHC-I alleles are associated with elite control. Two of the three viruses demonstrated reduced fitness in vivo, and 27% of the introduced mutations reverted. These findings suggest that T cell epitope diversity may not be such a daunting problem for the development of an HIV vaccine.

Indexed as

Virus ReplicationAmino Acid SequenceAnimalsCD8-Positive T-LymphocytesHistocompatibility Antigens Class IHumansMacaca mulattaMolecular Sequence DataMutationSequence Homology, Amino AcidSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusHistocompatibility Antigens Class I

Identifiers

PMID21957309
PMCPMC3209381
OpenAlexW1978622866

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.